Pavmed inc. (PAVM)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15
Cash flows from operating activities
Net loss - before noncontrolling interest

-17,268

-18,172

-

-

-

Net loss - before noncontrolling interest

-

-

-9,519

-

-

Net loss

-

-

-

-5,650

-1,776

Adjustments to reconcile net loss - before NCI to net cash used in operating activities
Depreciation expense

14

9

7

3

-

Stock-based compensation

1,570

1,228

1,048

747

-

Interest expense added to principal of Senior Secured Note

-

591

-

-

-

Interest expense added to principal of Senior Secured Note

-

-

188

0

-

Interest expense - amortization of debt discount - Senior Secured Note

-

1,606

347

-

-

Debt extinguishment - Senior Secured Convertible Notes

-1,831

-

-

-

-

Debt extinguishment - Senior Secured Note

-

-1,408

-

-

-

Change in fair value - Senior Secured Convertible Note

558

903

-

-

-

Modification expense - Series Z Warrant

-

1,140

-

-

-

Series A and Series A-1 Exchange Offer - March 15, 2018

-

-349

-

-

-

Modification expense - Series A-1 Warrant

-

-

222

-

-

Modification of Series A-1 Warrant agreement

-

-

-

0

-

Amortization of discount - Senior Secured Note

-

-

-

0

-

Series W Warrants Exchange Offer - April 5, 2018

-

766

-

-

-

Unit Purchase Options Exchange Offer - August 22, 2018

-

2

-

-

-

Loss - Series A Preferred Stock Units private placement

-

-

3,124

0

-

Change in fair value - Series A Warrants derivative liability

-

96

-1,942

0

-

Change in fair value - Series A Convertible Preferred Stock conversion option derivative liability

-

-64

-643

0

-

Expense attributable to contributed services

-

-

-

-

133

Changes in operating assets and liabilities:
Prepaid expenses and other current assets

90

149

-67

146

5

Accounts payable

613

872

-83

877

100

Accrued expenses and other current liabilities

56

623

575

-286

298

Deposits - Long-Term

-643

-

-

-

-

Net cash flows used in operating activities

-13,357

-8,787

-6,608

-

-

Cash flows from investing activities
Net cash flows used in operating activities

-

-

-

-4,454

-1,249

Purchase of equipment

27

26

5

21

-

Net cash flows used in investing activities

-27

-26

-5

-

-

Cash flows from financing activities
Proceeds from issuance of Series A-1 Preferred Stock Units

-

-

-

0

-

Proceeds - issue of Senior Secured Convertible Note

-

7,000

4,842

0

-

Repayment of debt - Senior Secured Note

-

5,000

-

-

-

Payment - offering costs - underwritten public offering

-

-

-

1,004

-

Proceeds - issue of units in an equity subscription rights offering

-

9,437

-

-

-

Payment - offering costs - equity subscription rights offering

-

225

-

-

-

Proceeds - issue of common stock in an underwritten public offering

-

4,388

-

5,300

-

Payment - offering costs - underwritten public offering

-

-113

-

-

-

Proceeds - issue of common stock of majority-owned subsidiary

-

1

-

-

-

Proceeds - issue of common stock- registered offerings

5,480

-

-

-

-

Payment - offering costs - registered offerings

101

-

-

-

-

Proceeds - issue of Senior Convertible Note

6,300

-

-

-

-

Net cash flows used in investing activities

-

-

-

-21

-

Payment - issue of Senior Convertible Note

85

-

-

-

-

Payment - issue of Senior Convertible Note - non-installment

279

-

-

-

-

Proceeds - issue of common stock under employee stock purchase plan

67

-

-

-

-

Payment - Series A Convertible Preferred Stock Dividends

-

7

-

-

-

Proceeds - issue of Series A Preferred Stock Units private placement

-

-

2,537

0

-

Payment - offering costs - Series A Preferred Stock Units private placement

-

-

388

0

72

Proceeds - issue of Series A-1 Preferred Stock Units private placement

-

-

500

-

-

Proceeds - issue of common stock upon exercise of warrants, net

-

20

71

-

-

Net cash flows provided by financing activities

11,381

15,501

7,562

-

-

Net increase (decrease) in cash

-2,002

6,687

-

-

-

Proceeds from common stock issued upon exercise of warrants

-

-

-

0

1,250

Net cash flows provided by financing activities

-

-

-

4,295

1,177

Net (decrease) increase in cash

-

-

949

-181

-71

Deferred offering costs in connection with initial public offering

-

-

-

-

365